Skip to main content

Find a Tender · Forecast

Birmingham Women's and Children's NHS Foundation Trust

BWC Genomics Interoperability and Data Sharing - Market Engagement

Forecast · PlanningNo open deadline

Forecast: a planned procurement that is not yet at tender stage.

01/ The notice

Key facts

Value
£1,500,000Estimated value stated in the notice
Deadline (UK time)
No open deadlineA deadline does not apply to this forecast notice.
Published
4 Jun 2026
Region
Not stated

02/ The brief

What the notice says

Not fully read: this is the notice text; attached documents are not read.

BWCH is an NHS Foundation Trust formed in February 2017, providing care from their two main sites – The Birmingham Women’s Hospital and Birmingham Children’s Hospital. The Trust has more than 641,000 visits from patients each year and employs a workforce of 6,000 staff members.

The Trust has a history of innovation and research including conducting the first operation for ectopic pregnancy and caesarean section for hemorrhage in late pregnancy, fitting the world’s first pacemaker into a three-day-old baby, being the first in the world to separate two twins conjoined at the spine, performing the first triple transplant of liver, pancreas and small bowel in the UK, and being the first to launch a community mental health service for patients aged 0-25 years – i.e. Forward Thinking Birmingham (FTB).

The Trust also hosts the Central and South Genomic Medicine Service, (C&S GMS). This regional service forms part of a network of seven GMS’s across England who together deliver the national genomic testing service and play a pivotal role in embedding genomics in routine care.

C&S GMS provides genomic testing across the West Midlands, Oxford and Thames Valley, and Wessex, serving a population of approximately 10 million. C&S GMS is formed across four partner Trusts: Birmingham Women’s and Children’s Hospital (BWCH), University Hospital Birmingham (UHB), University Hospital Southampton (UHS), and Oxford University Hospital (OUH).

This PME outlines the requirements of the C&SGMS to deduplicate testing between sites and enable a Distributed Analysis (DA) model of genomic testing.

The requirements documented are vendor agnostic and have been developed to inform the selection and implementation of a DA solution. Our C&S GMS is required to function as one laboratory across several sites and therefore needs to integrate multiple systems to deliver patient care. We want to have a range of functionality across multiple operational activities within a single system.

Please note the Contract Value is an estimate factoring in the maximum budget for Year 1 and should only be used as an example only.

Please see the Briefing note within the PME documents for more information.

03/ Classification

CPV codes

Common Procurement Vocabulary codes, exactly as the notice lists them. No descriptions are added here.

  • 48000000

04/ History

Releases of this notice

One release held, oldest first. Dates are UK time.

  1. 4 Jun 2026
    Planning notice

    Planning notice published 4 June 2026.

    Release 052908-2026

    View this release on Find a Tender (opens in a new tab)

05/ Limits

What the source does not tell us

  • Only one release is held, so there is no change history.

06/ Questions

About this notice

Birmingham Women's and Children's NHS Foundation Trust published this notice.

Estimated value stated in the notice: £1,500,000.

07/ Related

Where to go next

These links follow a fixed rule applied to this notice’s buyer, text and CPV codes. They are not advice on whether to bid.

Reference
ocds-h6vhtk-06adbd
Source
Find a Tender
Stage
planning · Planning
Last verified
Wed 10 Jun 2026, 08:08 BST
Read at
Mon 19 Oct 2026, 11:05 BST

Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.

RFP Quest logo — RFP software, RFP platform and RFP tools

Built on published notices from Find a Tender and Contracts Finder.

15 minutes · RFP Quest

Book a Demo